|
|
Article: Indian firms, Clinton Foundation sign deal on malaria drugs
- Article from:
- The Hindustan Times
- Article date:
- July 18, 2008
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
Report from Indo-Asian News Service brought to you by HT Syndication.
New York, July 18 -- Four Indian and two Chinese companies will cut the price of a key malaria drug and control rates of a vital ingredient following a pact signed Thursday with the US-based Clinton Foundation, which works towards finding solutions to issues such as poverty and healthcare.
The Indian companies are generic drug firms Cipla and IPCA Laboratories, which manufacture malaria drugs called Artemisinin-based Combination Therapy (ACT), and Calyx and Mangalam Drugs, which turn the artemisinin plant extract into an active pharmaceutical ingredient.
China's Holleypharm and PIDI Standard grow the plants.
Under the ...